calaspargase
Selected indexed studies
- Calaspargase Pegol. (, 2006) [PMID:35073033]
- Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001. (J Clin Oncol, 2021) [PMID:34228505]
- ** (, 2024) [PMID:38917259]
_Worker-drafted node — pending editorial review._
Connections
calaspargase is a side effect of
Sources
- Calaspargase Pegol. (2006) pubmed
- Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001. (2021) pubmed
- PMID:38917259 (2024) pubmed
- PMID:38564534 (2024) pubmed
- Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia. (2024) pubmed
- Severe hypertriglyceridemia associated with calaspargase pegol. (2025) pubmed
- Calaspargase pegol and pegaspargase cause similar hepatosteatosis in mice. (2025) pubmed
- Space for Calaspargase? A New Asparaginase for Acute Lymphoblastic Leukemia. (2020) pubmed
- Attempted desensitization to calaspargase pegol: a familiar approach to a new problem. (2024) pubmed
- A 12-Step Desensitization Protocol for Calaspargase Pegol-mknl. (2025) pubmed